Advanced Medical Solutions Group Interim Report 2025

AMS's H1 2025 interim report highlights 63% reported revenue growth to £110.8 million, driven by the Peters Surgical acquisition and organic expansion across tissue-healing and surgical product lines. The company demonstrates strong operational performance with improved manufacturing efficiencies and emerging commercial synergies across specialty markets.